• Je něco špatně v tomto záznamu ?

Diazepam filled hard capsules intended for detoxification of patients addicted to benzodiazepines and Z-drugs

A. Franc, K. Kubová, J. Elbl, J. Muselík, D. Vetchý, J. Šaloun, R. Opatřilová,

. 2019 ; 26 (1) : 10-15. [pub] 20170724

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028933
E-zdroje Online Plný text

NLK PubMed Central od 2016
Europe PubMed Central od 2016 do Před 1 rokem
ProQuest Central od 2012-02-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2012-02-01 do Před 6 měsíci

Objectives: The abuse of benzodiazepines and Z-drugs reduces the quality of life of millions of addicted people worldwide. They cannot be discontinued abruptly due to harmful withdrawal symptoms. Detoxification is usually based on replacement of short/middle acting benzodiazepines or Z-drugs by diazepam and tapering the dose over time. In order to enhance patient adherence to an individual withdrawal plan, suitable diazepam dosage forms have to be available. Hard capsules containing an exact and uniform dose could be used for the relief of symptoms caused by altering the plasma level and overcoming psychogenic stress from the dose reduction. Methods: This work demonstrates that capsules with a content of diazepam ranging from 2.125mg to 0.492 mg (dose decreasing always by 15%) cannot be easily prepared by standard mortar technology in a pharmacy. To meet mass and content uniformity European Pharmacopoeia criteria, capsules were prepared by improved technology based on the preparation of binary blends of calcium phosphate anhydrous and diazepam in descending concentrations in a high-speed mixer (time 30 s) and densification of about 10% during filling of the capsules. Results: All batches (n=20) prepared by improved technology met the requirement for content uniformity compared with only nine batches prepared by standard mortar blender technology. Based on the process capability index, none of the samples prepared by standard technology fitted pharmacopeia limits at the statistically acceptable level. On the other hand, all batches prepared by improved technology exhibited acceptable process capability index. Conclusions: We have shown that at least 99.73% of batches prepared by our improved technology would meet the pharmacopoeia limits for content uniformity and are suitable for treatment of this type of addiction.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028933
003      
CZ-PrNML
005      
20190815105328.0
007      
ta
008      
190813s2019 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/ejhpharm-2016-001163 $2 doi
035    __
$a (PubMed)31157089
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Franc, Aleš $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
245    10
$a Diazepam filled hard capsules intended for detoxification of patients addicted to benzodiazepines and Z-drugs / $c A. Franc, K. Kubová, J. Elbl, J. Muselík, D. Vetchý, J. Šaloun, R. Opatřilová,
520    9_
$a Objectives: The abuse of benzodiazepines and Z-drugs reduces the quality of life of millions of addicted people worldwide. They cannot be discontinued abruptly due to harmful withdrawal symptoms. Detoxification is usually based on replacement of short/middle acting benzodiazepines or Z-drugs by diazepam and tapering the dose over time. In order to enhance patient adherence to an individual withdrawal plan, suitable diazepam dosage forms have to be available. Hard capsules containing an exact and uniform dose could be used for the relief of symptoms caused by altering the plasma level and overcoming psychogenic stress from the dose reduction. Methods: This work demonstrates that capsules with a content of diazepam ranging from 2.125mg to 0.492 mg (dose decreasing always by 15%) cannot be easily prepared by standard mortar technology in a pharmacy. To meet mass and content uniformity European Pharmacopoeia criteria, capsules were prepared by improved technology based on the preparation of binary blends of calcium phosphate anhydrous and diazepam in descending concentrations in a high-speed mixer (time 30 s) and densification of about 10% during filling of the capsules. Results: All batches (n=20) prepared by improved technology met the requirement for content uniformity compared with only nine batches prepared by standard mortar blender technology. Based on the process capability index, none of the samples prepared by standard technology fitted pharmacopeia limits at the statistically acceptable level. On the other hand, all batches prepared by improved technology exhibited acceptable process capability index. Conclusions: We have shown that at least 99.73% of batches prepared by our improved technology would meet the pharmacopoeia limits for content uniformity and are suitable for treatment of this type of addiction.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kubová, Kateřina $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Elbl, Jan $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Muselík, Jan $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Vetchý, David $u Department of Pharmaceutics, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Šaloun, Jan $u Department of Applied Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
700    1_
$a Opatřilová, Radka $u Department of Chemical Drugs, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
773    0_
$w MED00200143 $t European journal of hospital pharmacy : science and practice $x 2047-9964 $g Roč. 26, č. 1 (2019), s. 10-15
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31157089 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190815105556 $b ABA008
999    __
$a ind $b bmc $g 1434082 $s 1067393
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 26 $c 1 $d 10-15 $e 20170724 $i 2047-9964 $m European journal of hospital pharmacy $n Eur J Hosp Pharm $x MED00200143
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace